[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

De Kivit et al., 2014 - Google Patents

Regulation of intestinal immune responses through TLR activation: implications for pro-and prebiotics

De Kivit et al., 2014

View HTML
Document ID
11465097784331028357
Author
De Kivit S
Tobin M
Forsyth C
Keshavarzian A
Landay A
Publication year
Publication venue
Frontiers in immunology

External Links

Snippet

The intestinal mucosa is constantly facing a high load of antigens including bacterial antigens derived from the microbiota and food. Despite this, the immune cells present in the gastrointestinal tract do not initiate a pro-inflammatory immune response. Toll-like receptors …
Continue reading at www.frontiersin.org (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Similar Documents

Publication Publication Date Title
De Kivit et al. Regulation of intestinal immune responses through TLR activation: implications for pro-and prebiotics
Pascal et al. Microbiome and allergic diseases
Yahfoufi et al. Role of probiotics and prebiotics in immunomodulation
Costabile et al. Effects of soluble corn fiber alone or in synbiotic combination with Lactobacillus rhamnosus GG and the pilus-deficient derivative GG-PB12 on fecal microbiota, metabolism, and markers of immune function: a randomized, double-blind, placebo-controlled, crossover study in healthy elderly (Saimes study)
West et al. Bugging allergy; role of pre-, pro-and synbiotics in allergy prevention
Zeuthen et al. Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gram-negative bacteria
Wallace et al. Human gut microbiota and its relationship to health and disease
Menard et al. Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport
Fitzgibbon et al. The microbiota and immune‐mediated diseases: Opportunities for therapeutic intervention
Yan et al. Probiotics and immune health
Dong et al. Selective effects of Lactobacillus casei Shirota on T cell activation, natural killer cell activity and cytokine production
Thomas et al. Probiotics-host communication: modulation of signaling pathways in the intestine
Plaza-Diaz et al. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics
Brown et al. A fresh look at the hygiene hypothesis: how intestinal microbial exposure drives immune effector responses in atopic disease
McLoughlin et al. Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma
Roessler et al. The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention
Medina et al. Bifidobacterium strains suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patients
Karamese et al. The immunostimulatory effect of lactic acid bacteria in a rat model
Díaz‐Ropero et al. Two Lactobacillus strains, isolated from breast milk, differently modulate the immune response
Hakansson et al. Gut microbiota and inflammation
Donkor et al. Cytokine profile and induction of T helper type 17 and regulatory T cells by human peripheral mononuclear cells after microbial exposure
Rask et al. Differential effect on cell-mediated immunity in human volunteers after intake of different lactobacilli
Reading et al. The starting lineup: key microbial players in intestinal immunity and homeostasis
You et al. Evidence of immunomodulatory effects of a novel probiotic, Bifidobacterium longum bv. infantis CCUG 52486
Bandyopadhyay et al. Probiotics, prebiotics and synbiotics-in health improvement by modulating gut microbiota: the concept revisited